COVID-19

Latest News

March 28th 2025

Here are highlights from this week in Psychiatric Times, including positive clinical trial news for an ADHD treatment and an exclusive interview on the joint statement defending psychotropic medication safety.

Post-Acute Sequelae of COVID-19 Infection Presenting With Neuropsychiatric Symptoms: Diagnosis and Management

By Meghan Reddy, MD
Kalyn Reddy, MD, MPH

March 28th 2025

How Not to Mourn COVID-19

By H. Steven Moffic, MD

March 17th 2025

The 5-Year Anniversary of COVID-19

By Nidal Moukaddam, MD, PhD

March 11th 2025

Psilocybin Benefits Clinicians Traumatized on Front Line of COVID-19 Pandemic

By Kenneth J. Bender, PharmD, MA

March 11th 2025

Video Interviews

Podcasts

Latest CME Events & Activities

Expert Perspectives in the Recognition and Management of Postpartum Depression

Southern California Psychiatry Conference

July 11-12, 2025

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Southern Florida Psychiatry Conference

November 21-22, 2025

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

More News

COVID-19, 5 Years Later

Mike Hennessy Jr

March 6th 2025

The impacts of this pandemic continue to ripple. All we can do is try our best to stay informed. That’s where we come in.

Psychiatric Times Through the Years: The Last 5 Years in March Covers

Megan McSweeney

March 3rd 2025

Celebrate Psychiatric Times’ 40th anniversary with a look back at some of our previous covers.

Psychiatric Times Through the Years: The Last 5 Years in February Covers

Megan McSweeney

February 22nd 2025

Celebrate Psychiatric Times’ 40th anniversary with a look back at some of our previous covers.

Psychiatric Times Through the Years: the Last 5 Years in January Covers

Megan McSweeney

January 31st 2025

Celebrate Psychiatric Times’ 40th anniversary with a look back at some of our previous covers.

A Prescription for Loneliness: Mitigating Social Isolation and Loneliness in Older Adults

Temitope Ogundare, MD, MPH

January 29th 2025

How should clinicians approach loneliness in elderly patients, and how can technology assist in treatment?

How Do You Feel? One Doctor’s Search for Humanity in Medicine

Parma J. Zahid, MD

January 9th 2025

Jessi Gold, MD, MS, writes about the emotional challenges of healthcare during the COVID-19 pandemic. Through patient stories and her own reflections, she uncovers what happens when clinicians are asked to "feel."

A Social Psychiatrist Looks Back on 2024 and Forward to 2025: Hurry Up and Slow Down!

Vincenzo Di Nicola, MPhil, MD, PhD, FCAHS, DLFAPA, DFCPA, FACPsych

December 6th 2024

Festina lente—hurry up and slow down!

Reduced Blood Monitoring and Hematological Abnormalities in Clozapine-Treated Patients

Brian Miller, MD, PhD, MPH

September 27th 2024

Does reduced blood monitoring impact the detection of hematological abnormalities in clozapine-treated patients? Researchers performed a chart review study from the COVID-10 pandemic.